NPR1 Gene (Natriuretic Peptide Receptor 1)

Guanylyl Cyclase Receptor for Atrial and B-Type Natriuretic Peptides

Gene Information Card

Symbol NPR1
Full Name Natriuretic Peptide Receptor 1
Gene Type protein-coding
Chromosomal Location 1q21.3
NCBI Gene ID 4881 ncbi.nlm.nih.gov/gene/4881
Ensembl ID ENSG00000169418
UniProt ID P16066
OMIM ID 108960
HGNC ID 7939
Aliases ANPa, ANPRA, GUCY2A, GUCYA2, NPRA

Description

NPR1 encodes the natriuretic peptide receptor A (NPRA), a transmembrane guanylyl cyclase that serves as the receptor for atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP). Binding of these ligands activates intracellular guanylyl cyclase activity, increasing cGMP levels, which mediates vasodilation, natriuresis, and inhibition of renin and aldosterone secretion. NPR1 is critical for blood pressure regulation and fluid homeostasis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypertension Loss-of-function variants reduce cGMP signaling, impairing vasodilation and sodium excretion, leading to elevated blood pressure. ClinVar, OMIM
Heart Failure Reduced NPR1 expression or activity diminishes the compensatory natriuretic peptide response, contributing to fluid overload and cardiac remodeling. NCBI Gene, OMIM
Atrial Fibrillation Polymorphisms in NPR1 have been associated with increased risk of atrial fibrillation, possibly through altered atrial natriuretic peptide signaling. ClinVar, PubMed (via NCBI)

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 0.2 Not detected
Adrenal gland 1.5 Low
Heart 12.3 Medium
Kidney 18.7 Medium
Lung 6.4 Low
Vascular smooth muscle 8.9 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK 293 15.2 Moderate expression
HUVEC 22.1 High expression
A549 3.4 Low expression
MCF7 1.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1024G>A (p.Val342Met) Missense 0.001% Reduced guanylyl cyclase activity; associated with hypertension
c.2077C>T (p.Arg693*) Nonsense <0.001% Loss of function; truncation of cytoplasmic domain
c.2456A>G (p.Asn819Ser) Missense 0.002% Impaired ligand binding; linked to heart failure
Mutation functional classification

Loss of Function (LOF)

Most NPR1 mutations are loss-of-function, reducing cGMP production and impairing natriuretic peptide signaling, leading to hypertension and fluid retention.

Gain of Function (GOF)

Rare gain-of-function mutations have been reported, enhancing guanylyl cyclase activity and potentially causing hypotension.

Dominant Negative (DN)

Some missense mutations in the extracellular domain may exert dominant-negative effects by forming inactive dimers with wild-type receptors.

Gene Ontology (GO)

• GO:0004383 (guanylate cyclase activity) • GO:0005524 (ATP binding)
• GO:0005886 (plasma membrane) • GO:0007165 (signal transduction)
• GO:0006182 (cGMP biosynthetic process) • GO:0019899 (enzyme binding)

Pathways

Natriuretic peptide signaling pathway (Reactome: R-HSA-418594)
cGMP-PKG signaling pathway (KEGG: hsa04022)
Renin-angiotensin system (KEGG: hsa04614)

Protein Summary

Natriuretic peptide receptor 1 (NPRA) is a 1061-amino acid transmembrane protein with an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular guanylyl cyclase domain. It forms homodimers and, upon ANP or BNP binding, catalyzes the conversion of GTP to cGMP. NPRA is expressed primarily in kidney, heart, adrenal gland, and vascular smooth muscle, where it regulates blood pressure, fluid balance, and cardiac function.

Related Products

Product name Cat.No. Species Gene ID
NPR1 Knockout HEK293 Cell Line EDJ-KQ1777 Human 4881 Details Get a Quote
NPR1 Knockout HeLa Cell Line EDC90145 Human 4881 Details Get a Quote
NPR1 Knockout A-549 Cell Line EDJ-KQ21644 Human 4881 Details Get a Quote
NPR1 Knockout HCT 116 Cell Line EDJ-KQ70976 Human 4881 Details Get a Quote
Npr1 Knockout HL-1 Cell Line EDC07579 Mouse 18160 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: